7 Best Pancreatic Cancer Treatment Doctors in Faridabad for 2026

Introduction

The CT scan is finished, and the words 'pancreatic mass' sit heavy on the report. Pancreatic cancer, a disease that often develops quietly with few symptoms until it is advanced, demands decisions that feel impossibly urgent. You need a coordinated team in Faridabad, not a flight away.

The best pancreatic cancer treatment doctors in Faridabad are concentrated under one roof at Sarvodaya Cancer Institute, anchored by three sub-specialists whose coordinated expertise covers every stage of this disease. This article profiles each of them, maps the integrated treatment hub they operate within, and gives you the stage-wise decision framework to know exactly who to see first.

Key Takeaways

A pancreatic cancer diagnosis forces families into decisions they aren't ready for. The difference between good and excellent care comes down to one structural reality: treatment planned by a mandatory multidisciplinary team before a single incision or infusion, not by solo specialists working sequentially.

• Coordinated Specialist Hub: Three core specialists at Sarvodaya Cancer Institute, a dedicated GI surgeon, a medical oncology lead, and a clinical governance veteran with over 41 years of experience, practice together under one roof. You see them as a coordinated unit instead of chasing referrals across town

• Sub-Specialist Surgical Requirement: A Whipple procedure demands a GI oncology surgeon who performs it at high volume, trained at a high-volume center. Dr. Bharat Patodiya in Faridabad fits that profile. A general surgeon is the wrong call here

• Mandatory Tumor Board Governance: The single most important institutional safeguard is a mandatory multidisciplinary tumor board. Radiologists, surgeons, and oncologists plan treatment collaboratively before it begins. At Sarvodaya, that process directly changes treatment strategy

• Transparent Access and Pricing: Dr. Bharat Patodiya lists a consultation fee of ₹1,500.00, with potential same-week availability. You know the cost before you walk in

• Full-Spectrum Local Modalities: Every major evidence-based modality, the FOLFIRINOX chemotherapy regimen, IMRT precision radiotherapy, robotic minimally invasive surgery, is available locally in Faridabad, aligned to NCCN, ESMO, and ASCO international guidelines.

1. Dr Bharat Patodiya, The Dedicated GI Surgeon for Resectable and Borderline Pancreatic Cancer

Dr. Bharat Patodiya's profile answers the important question for operable pancreatic cancer: a surgeon whose core identity is gastrointestinal oncology, not general surgery. The table below maps this requirement against the credentialing and volume specifics that matter for outcomes.

2. Dr Brahamjit Singh, The Medical Oncology Lead for Advanced and Metastatic Pancreatic Cancer

When pancreatic cancer is borderline resectable, locally advanced, or metastatic, your first stop is a medical oncologist, not a surgeon. Dr. Brahamjit Singh directs the systemic therapy program at Sarvodaya Cancer Institute and runs the neoadjuvant and palliative chemotherapy protocols that frame most modern pancreatic cancer treatment. His job is to shrink a borderline tumor enough for surgery, keep widely metastatic disease under control, and pick therapies based on molecular data.

He administers FOLFIRINOX, a regimen that extends median overall survival to 11 months in advanced pancreatic cancer, along with gemcitabine-based combinations and molecularly guided targeted agents.

Under his direction, systemic therapy sits at the center of the plan rather than as a footnote to surgery. For a patient with a borderline tumor, Dr. Singh's neoadjuvant chemotherapy can create the window that makes a subsequent Whipple procedure feasible.

3. Dr Dinesh Pendharkar, The 41-Year Clinical Governance Expert and Multidisciplinary Board Anchor

Dr. Dinesh Pendharkar oversees the mandatory multidisciplinary tumor board at Sarvodaya Cancer Institute with over 41 years of clinical oncology experience. This is not a casual case discussion. A multidisciplinary tumor board is a meeting of healthcare professionals from different specialties to discuss and recommend a personalized treatment plan for each patient.

His role is to ensure that no treatment plan leaves the room without radiologic, surgical, and medical oncology consensus. Research from a tertiary referral center confirms that a multidisciplinary tumor board alters diagnosis, staging, or treatment plans in a substantial proportion of pancreatic cases, with the impact being evaluated across pancreatic ductal adenocarcinoma, neuroendocrine tumors, and other pathologies.

This governance layer is what prevents the all-too-common scenario of a surgeon operating prematurely on a patient who needed neoadjuvant chemotherapy first, or a medical oncologist pursuing systemic therapy when a surgical window is closing. His veteran oversight institutionalizes best practice, directly affecting the treatment strategy change rate that drives survival in a time-sensitive disease.

4. Sarvodaya Cancer Institute as the Integrated Treatment Hub for Pancreatic Cancer in Faridabad

Sarvodaya Cancer Institute houses surgery, precision radiotherapy (IMRT and IGRT), systemic therapies, and supportive care under one workflow. A patient moving from staging to neoadjuvant chemotherapy, then to a Whipple procedure, and finally to adjuvant radiation stays with a single coordinated team. No handoff gaps. No new set of doctors halfway through treatment.

The institute runs contrast-enhanced CT, MRI with MRCP for ductal mapping, and endoscopic ultrasound for tissue diagnosis on-site. PET-CT is also available. A positive EUS-guided biopsy flows directly into molecular profiling and then to the tumor board, where the plan is aligned with NCCN and ESMO guidelines. When the CT is ambiguous or biliary involvement is suspected, MRI with MRCP clarifies the ductal anatomy.

For out-of-town or time-constrained families, the institute opens a fast entry channel. Online consultations include a video review of your scans and reports within a 24 to 48-hour window. The typical output is a coordinated treatment plan that sidesteps the dangerous delays pancreatic cancer does not forgive.

5. Staging Essentials and Diagnostic Accuracy for Treatment Planning in Faridabad

You must complete a precise staging workup before choosing between a surgeon and an oncologist. The imaging and tissue diagnosis determines whether a tumor is resectable, borderline resectable, locally advanced, or metastatic, and this decision point governs your entire treatment entry:

1. Contrast-enhanced CT: Remains the gold standard for diagnosing and staging pancreatic cancer, giving the first clear look at vascular involvement and the tumor's relationship to the superior mesenteric artery.

2. MRI with MRCP: Steps in when the CT is ambiguous or biliary involvement is suspected.

3. PET-CT: Rules out or confirms distant metastases, reclassifying the disease as stage IV and redirecting you to medical oncology first.

4. Endoscopic ultrasound (EUS) with fine-needle biopsy: Provides the tissue for cytological diagnosis and increasingly for molecular profiling and biomarker analysis, which can open eligibility for targeted therapy later.

6. Advanced Treatment Modalities for Every Stage of Pancreatic Cancer

Faridabad's treatment stack at Sarvodaya Cancer Institute matches the full modern oncology toolkit required for every stage of pancreatic cancer, eliminating the historical need to travel to a metro center like Delhi or Mumbai. This sequence maps the major modalities to their clinical purpose.

1. Surgical Resection for Resectable and Borderline Disease: The Whipple procedure, distal pancreatectomy, and total pancreatectomy are the definitive operations, often performed with minimally invasive and robotic techniques that reduce blood loss, postoperative pain, and recovery time significantly.

2. Systemic Chemotherapy for Borderline, Locally Advanced, and Metastatic Disease: FOLFIRINOX and gemcitabine-based regimens, including their molecularly guided targeted therapy combinations, form the backbone of neoadjuvant and palliative treatment administered by the medical oncology team.

3. Precision Radiotherapy for Locally Advanced Disease and Palliation: IMRT and IGRT technologies deliver high-dose radiation to the pancreatic tumor bed while sparing the surrounding duodenum, stomach, and kidneys, offering local control when surgery is not possible.

4. Molecularly Guided Targeted Therapy for Metastatic Disease: For patients with specific actionable mutations identified on EUS biopsy profiling, targeted agents can be integrated into the chemotherapy plan, moving beyond a one-size-fits-all cytotoxic approach where the profile warrants it.

5. Supportive and Palliative Care Integration: From the moment of diagnosis, pain management, nutritional support, and biliary decompression for jaundiced patients are integrated into the care plan, not relegated to the very end of the disease course.

7. A Stage-Wise Decision Guide to the Right Specialist and Treatment Entry Point

The stage of the disease at diagnosis dictates the specialist you should see first. A resectable tumor seen clearly on a contrast-enhanced CT, with no vascular abutment or distant spread, belongs first on Dr. Bharat Patodiya's surgical schedule. In this scenario, the tumor board typically confirms a direct-to-surgery pathway. His Whipple experience and GI-focused procedural volume become the most important variables in the room.

A borderline resectable tumor changes the sequence. This is a tumor that touches the mesenteric vessels but does not encase them. Here, you should see Dr. Brahamjit Singh first. The standard of care is neoadjuvant FOLFIRINOX chemotherapy for several cycles, followed by a restaging CT. Only after the tumor has been chemosensitized and pulled back from the vessels does Dr. Patodiya's surgical window open.

Locally advanced, unresectable disease, where the tumor wraps the artery, requires permanent systemic therapy with possible consolidative IMRT radiation. Dr. Singh remains your lead clinician here. The radiation oncologist and Dr. Dinesh Pendharkar's tumor board governance ensure that the boundaries between futile surgical attempts and appropriate local control are maintained.

Metastatic, or stage IV, disease means the cancer has traveled to the liver, lungs, or peritoneal lining. Your treatment entry point is medical oncology. An initial biopsy for molecular profiling can guide a targeted therapy overlay on a gemcitabine-based or FOLFIRINOX chemotherapy backbone, a treatment philosophy that Dr. Singh directs to maximize both survival and quality of life.

Conclusion

The best pancreatic cancer care in Faridabad comes from a tumor board of three distinct specialists working together at one institution. Gather your contrast-enhanced CT, any MRI or PET-CT reports, and a tissue biopsy if you have one. Submit them for an initial online consultation.

Sarvodaya Cancer Institute's protocol includes a video review of your scans and a coordinated treatment plan within 24 to 48 hours. That turnaround matters. Pancreatic cancer doesn't wait, and neither should the path to a decision.

Frequently Asked Questions

Who are the top medical oncologists specializing in pancreatic cancer treatment in Faridabad?

The top specialists are concentrated at Sarvodaya Cancer Institute. Dr. Bharat Patodiya is the dedicated GI oncology surgeon. Dr. Brahamjit Singh directs systemic chemotherapy for advanced stages, and Dr. Dinesh Pendharkar provides over 41 years of clinical governance over the mandatory multidisciplinary tumor board.

What qualifications and experience should I look for in a pancreatic cancer doctor in Faridabad?

Look for dedicated sub-specialist training, not just a general oncology background. A GI surgeon should have high procedural volume in Whipple procedures and training from a high-volume center. A medical oncologist should direct chemotherapy protocols like FOLFIRINOX and integrate molecular profiling into targeted therapy plans.

How much does a consultation with a pancreatic cancer specialist cost in Faridabad?

A consultation typically ranges from ₹1,500 to ₹3,000. Dr. Bharat Patodiya, for instance, lists transparent pricing on his site, showing a consultation fee with a regular price of ₹1,500.00 and an online sale price of ₹1,050.00. Other specialists at the center may vary within this range.

What advanced treatment options and diagnostic services are available for pancreatic cancer in Faridabad?

Sarvodaya Cancer Institute provides the full spectrum: surgery including robotic Whipple procedures, systemic therapy with FOLFIRINOX and gemcitabine-based regimens, IMRT precision radiotherapy, molecularly guided targeted therapy, and a full diagnostic suite including contrast-enhanced CT, MRI/MRCP, PET-CT, and endoscopic ultrasound.

How do I choose the best hospital or cancer care center for pancreatic cancer treatment in Faridabad?

Prioritize a center that mandates a multidisciplinary tumor board where a surgeon, medical oncologist, and radiologist review your case together under one roof. The institution should also have all core staging technology on-site to avoid fragmented scans and delays between diagnosis and treatment initiation.

Can I get an online consultation with a pancreatic cancer specialist in Faridabad, and what does it involve?

Yes, online consultations are available. The process involves submitting your existing scans, biopsy reports, and medical history for a video review. At Sarvodaya Cancer Institute, the turnaround is typically 24 to 48 hours, after which you receive a coordinated treatment plan from the sub-specialist appropriate for your cancer stage.

Sources

1. Best Pancreatic Cancer Treatment in Faridabad, Delhi NCR - www.sarvodayahospital.com

2. Best Oncologist in Faridabad | Dr. Novak Gupta - drnovakgupta.com

3. Dr. Bharat Patodiya | Best Medical Oncologist in Faridabad - www.aimsindia.com

4. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center - PMC - pmc.ncbi.nlm.nih.gov

5. The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center. - pubmed.ncbi.nlm.nih.gov